March 14, 2013 9:00 — 1 Comment

Second-Generation Clot Removal Devices May Revamp Standard Stroke Treatment

Doctors at the Stony Brook Medicine’s Cerebrovascular and Stroke Center are treating patients with novel blood clot removal devices, including those with large vessel blockages. The Solitaire Flow Restoration Device and the Trevo Device showed improved results over first-generation clot-removal devices in treating acute ishemic stroke. Clinical trials have revealed that such tools show promise in successfully revascularizing stroke patients. Click here for the full article.

This article was written by on Thursday, March 14th, 2013 at 9:00 am. Both comments and pings are currently closed.

One Comment

  1. Manuel López Portillo says:
    March 24, 2013 at 8:35 pm

    It is impressive – the clinical results in the use of the new devices. Unfortunately it was not available for a Colombian-Mexican 40-year-old soccer player patient that just died by hemorragic brain complications produced during the intravascular clot removing procedure.

    Report this comment

Calendar/Courses

106th Meeting of the Senior Society of Neurological Surgeons
June 6-9, 2015; Miami

Neuromonitoring in Neurosurgery
European Association of Neurosurgical Societies (EANS)
June 14-16, 2015; Verona, Italy

Rocky Mountain Neurosurgical Society 50th Annual Meeting
June 20-24, 2015; Colorado Springs, Colo.

CARS 2015 - 29th International Congress and Exhibition
June 24-27, 2015; Barcelona, Spain

Neurotrauma 2015
June 28-July 01, 2015; Santa Fe, N.M.

Interactive Calendar

Advertisements